Gagan Gases Limited (GAGAN.BO)
INR 25.6
(-1.42%)
INR 25.6
(-1.42%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 21.32 Million | 22.08 Million | 28.99 Million | 21.73 Million | - |
| Cost of Revenue | 14.35 Million | 14.84 Million | 22.04 Million | 15.8 Million | - |
| Gross Profit | 6.97 Million | 7.24 Million | 6.95 Million | 5.93 Million | - |
| Operating Expenses | 4.23 Million | 5.8 Million | 3.79 Million | 3.83 Million | - |
| Selling, General and Administrative Expenses | 4.23 Million | 672 Thousand | 216 Thousand | 242.35 Thousand | 205.6 Thousand |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | - | 23.55 Million | 1000.00 | 38 Thousand | - |
| Cost and Expenses | 17.24 Million | 20.65 Million | 25.83 Million | 19.64 Million | - |
| Operating Income | 4.07 Million | 24.99 Million | 3.18 Million | 2.25 Million | - |
| Interest Expense | 351 Thousand | 451 Thousand | 511 Thousand | 665 Thousand | 80.5 Thousand |
| Income Tax Expense | 286 Thousand | 5.88 Million | 2.12 Million | 1.28 Million | - |
| Earnings before Tax | 886 Thousand | 24.54 Million | 2.69 Million | 1.6 Million | - |
| Net Income | 600 Thousand | 18.66 Million | 572 Thousand | 323 Thousand | - |
| Earnings Per Share Basic | 0.15 | 4.13 | 0.13 | 0.07 | 0.11 |
| Earnings Per Share Diluted | 0.15 | 4.13 | 0.13 | 0.07 | 0.11 |
| Weighted Average Shares Outstanding | 4.12 Million | 4.51 Million | 4.51 Million | 4.51 Million | 4.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.12 Million | 4.51 Million | 4.51 Million | 4.51 Million | 4.51 Million |
| Gross Margin | 0.33 | 0.33 | 0.24 | 0.27 | - |
| EBIT Margin | 0.09 | 1.16 | 0.14 | 0.14 | - |
| Profit Margin | 0.03 | 0.84 | 0.02 | 0.01 | - |
| EBITDA | 1.85 Million | 2.11 Million | 3.88 Million | 2.86 Million | 964.82 Thousand |
| Earnings Before Tax Margin | 0.19 | 1.13 | 0.11 | 0.10 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 14.28 Million | 13.4 Million | 6.42 Million | 21.32 Million | 6.03 Million | 5.45 Million |
| Cost of Revenue | 11.76 Million | 11.02 Million | 4.35 Million | 13.69 Million | 3.85 Million | 3.56 Million |
| Gross Profit | 2.52 Million | 2.38 Million | 2.07 Million | 7.63 Million | 2.17 Million | 1.88 Million |
| Operating Expenses | 1.7 Million | 933 Thousand | 1.54 Million | 6.71 Million | 1.51 Million | 1.53 Million |
| Selling, General and Administrative Expenses | - | 933 Thousand | 965 Thousand | - | 883 Thousand | 927 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.7 Million | - | - | 319 Thousand | - | - |
| Cost and Expenses | 13.47 Million | 11.95 Million | 5.89 Million | 20.4 Million | 5.36 Million | 5.09 Million |
| Operating Income | 813 Thousand | 1.45 Million | 843 Thousand | 1.23 Million | 661 Thousand | 357 Thousand |
| Interest Expense | - | - | 351 Thousand | 351 Thousand | - | - |
| Income Tax Expense | 50 Thousand | -1.58 Million | 286 Thousand | 286 Thousand | -156.5 Thousand | -170 Thousand |
| Earnings before Tax | 813 Thousand | -123 Thousand | 492 Thousand | 887 Thousand | 661 Thousand | 357 Thousand |
| Net Income | 763 Thousand | -123 Thousand | 206 Thousand | 601 Thousand | 661 Thousand | 357 Thousand |
| Earnings Per Share Basic | 0.17 | -0.03 | 0.05 | - | 0.15 | 0.08 |
| Earnings Per Share Diluted | 0.17 | -0.03 | 0.05 | - | 0.15 | 0.08 |
| Weighted Average Shares Outstanding | 4.48 Million | 4.1 Million | 4.12 Million | 4.12 Million | 4.4 Million | 4.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.48 Million | 4.09 Million | 4.12 Million | 4.12 Million | 4.4 Million | 4.46 Million |
| Gross Margin | 0.18 | 0.18 | 0.32 | 0.36 | 0.36 | 0.35 |
| EBIT Margin | 0.06 | 0.00 | 0.13 | - | 0.11 | 0.07 |
| Profit Margin | 0.05 | -0.01 | 0.03 | 0.03 | 0.11 | 0.07 |
| EBITDA | 813 Thousand | 39.75 Thousand | 843 Thousand | - | 661 Thousand | 357 Thousand |
| Earnings Before Tax Margin | 0.06 | 0.11 | 0.13 | 0.06 | 0.11 | 0.07 |
KNO
SAM
ZER
ATH
8160
3539